DE60111025D1 - Verwendung von Topiramat zur Behandlung und Diagnostizierung von Atemstörungen während des Schlafens und Mittel zur Durchführung der Behandlung und Diagnose - Google Patents

Verwendung von Topiramat zur Behandlung und Diagnostizierung von Atemstörungen während des Schlafens und Mittel zur Durchführung der Behandlung und Diagnose

Info

Publication number
DE60111025D1
DE60111025D1 DE60111025T DE60111025T DE60111025D1 DE 60111025 D1 DE60111025 D1 DE 60111025D1 DE 60111025 T DE60111025 T DE 60111025T DE 60111025 T DE60111025 T DE 60111025T DE 60111025 D1 DE60111025 D1 DE 60111025D1
Authority
DE
Germany
Prior art keywords
diagnosis
treatment
topiramate
sleep
during sleep
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60111025T
Other languages
English (en)
Other versions
DE60111025T2 (de
Inventor
Jan Hedner
Ludger Grote
Lars Sjoestroem
Kaj Stenloef
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE60111025D1 publication Critical patent/DE60111025D1/de
Application granted granted Critical
Publication of DE60111025T2 publication Critical patent/DE60111025T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicinal Preparation (AREA)
  • Endoscopes (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
DE60111025T 2000-02-24 2001-02-14 Verwendung von Topiramat zur Behandlung und Diagnostizierung von Atemstörungen während des Schlafens und Mittel zur Durchführung der Behandlung und Diagnose Expired - Lifetime DE60111025T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0000601 2000-02-24
SE0000601A SE0000601D0 (sv) 2000-02-24 2000-02-24 Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet
PCT/SE2001/000315 WO2001062243A1 (en) 2000-02-24 2001-02-14 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method

Publications (2)

Publication Number Publication Date
DE60111025D1 true DE60111025D1 (de) 2005-06-30
DE60111025T2 DE60111025T2 (de) 2006-05-04

Family

ID=20278571

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60111025T Expired - Lifetime DE60111025T2 (de) 2000-02-24 2001-02-14 Verwendung von Topiramat zur Behandlung und Diagnostizierung von Atemstörungen während des Schlafens und Mittel zur Durchführung der Behandlung und Diagnose

Country Status (13)

Country Link
US (1) US7981443B2 (de)
EP (1) EP1261333B1 (de)
JP (1) JP4896334B2 (de)
AT (1) ATE296098T1 (de)
AU (2) AU2001232588B2 (de)
CA (1) CA2401000C (de)
DE (1) DE60111025T2 (de)
DK (1) DK1261333T3 (de)
ES (1) ES2243444T3 (de)
NZ (1) NZ520781A (de)
PT (1) PT1261333E (de)
SE (1) SE0000601D0 (de)
WO (1) WO2001062243A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04002709A (es) * 2001-09-24 2005-06-06 Johnson & Johnson Derivados articonvulsivos utiles para el tratamiento del sindrome de extremidades inquietas y trastorno periodico del movimiento de extremidades.
SE0400378D0 (sv) * 2004-02-17 2004-02-17 Jan Hedner Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet
AU2006291581A1 (en) * 2005-09-16 2007-03-22 Cereuscience Ab Method and means of preventing and treating sleep disordered breathing
CA2641821C (en) 2006-02-16 2017-10-10 Imthera Medical, Inc. An rfid-based apparatus, system, and method for therapeutic treatment of a patient
US9744137B2 (en) * 2006-08-31 2017-08-29 Supernus Pharmaceuticals, Inc. Topiramate compositions and methods of enhancing its bioavailability
US8039468B2 (en) * 2006-08-31 2011-10-18 The Governors Of The University Of Alberta Method of inhibition of respiratory depression using positive allosteric AMPA receptor modulators
US8298576B2 (en) 2006-11-17 2012-10-30 Supernus Pharmaceuticals, Inc. Sustained-release formulations of topiramate
MX2009003911A (es) * 2006-12-04 2009-05-28 Supernus Pharmaceuticals Inc Formulaciones de liberacion inmediata, mejoradas de topiramato.
US8071557B2 (en) * 2007-06-13 2011-12-06 Vivus, Inc. Treatment of pulmonary hypertension with carbonic anhydrase inhibitors
BRPI0818654A2 (pt) 2007-10-09 2015-04-07 Imthera Medical Inc Aparelho, sistema e método para estimulação seletiva
US8428725B2 (en) 2008-10-09 2013-04-23 Imthera Medical, Inc. Method of stimulating a Hypoglossal nerve for controlling the position of a patient's tongue
AU2010318651A1 (en) 2009-11-10 2012-05-03 Imthera Medical, Inc. System for stimulating a hypoglossal nerve for controlling the position of a patient's tongue
EP2521546A4 (de) * 2010-01-07 2013-06-26 Vivus Inc Behandlung des obstruktiven schlafapnoesyndroms mit einer kombination aus kohlenstoffanhydrasehemmer und einem zusätzlichen wirkstoff
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CA2958110A1 (en) * 2014-08-14 2016-02-18 Vivus, Inc. Treatment of sleep apnea with a combination of a carbonic anhydrase inhibitor and an aldosterone antagonist
MX369090B (es) 2016-05-11 2019-10-29 Hedner Jan Sultiame para el tratamiento de apnea del sueño.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US7056890B2 (en) * 1999-06-14 2006-06-06 Vivus, Inc. Combination therapy for effecting weight loss and treating obesity

Also Published As

Publication number Publication date
AU2001232588B2 (en) 2004-04-22
ES2243444T3 (es) 2005-12-01
CA2401000A1 (en) 2001-08-30
PT1261333E (pt) 2005-09-30
AU3258801A (en) 2001-09-03
JP4896334B2 (ja) 2012-03-14
EP1261333B1 (de) 2005-05-25
DK1261333T3 (da) 2005-08-29
NZ520781A (en) 2004-04-30
US20040082519A1 (en) 2004-04-29
SE0000601D0 (sv) 2000-02-24
EP1261333A1 (de) 2002-12-04
JP2003523384A (ja) 2003-08-05
CA2401000C (en) 2010-03-23
ATE296098T1 (de) 2005-06-15
WO2001062243A1 (en) 2001-08-30
DE60111025T2 (de) 2006-05-04
US7981443B2 (en) 2011-07-19

Similar Documents

Publication Publication Date Title
DE60111025D1 (de) Verwendung von Topiramat zur Behandlung und Diagnostizierung von Atemstörungen während des Schlafens und Mittel zur Durchführung der Behandlung und Diagnose
ATE410163T1 (de) Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens
EP3454816A1 (de) Vorrichtung, system und verfahren zur mechanischen kutanen nervenstimulation für schmerz-, schlaganfall-, stimmungs-, atmungs- bewegung-, schlaf- und vaskuläre wirkung
NO20064964L (no) Behandling av svekket respiratorisk funksjon
DE60227658D1 (de) Verfahren zur behandlung neurodegenerativer, psychiatrischer und anderer störungen mit deacetylaseinhibitoren
ATE207351T1 (de) Verwendung vonmodafinil zur behandlung von atemstillstand im schlaf und zentral erregten atembeschwerden
ATE348808T1 (de) Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten
ATE290906T1 (de) Aktive implantierbare medizinische vorrichtung mit verbesserten mitteln zum unterscheiden zwischen den phasen von wachzustand und schlafzustand
DE69616376D1 (de) Verwendung von Tiagabin zur Behandlung von Schlafstörungen
ATE225663T1 (de) Verfahren zur behandlung von mittelohrentzündung mittels uridintriphosphaten und verwandten mitteln
Cherington Proximal pain in carpal tunnel syndrome
DE602004017888D1 (de) Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure
US20220211319A1 (en) Non-invasive proprioceptive stimulation for treating epilepsy
ATE301462T1 (de) Verwendung von reboxetine zur behandlung neuropsychiatrischer beschwerden
ATE191342T1 (de) Verwendung von riluzol zur behandlung mitochondrialer erkrankungen
BR9908190A (pt) Processos para tratar a dor especìfica de fêmea em um paciente fêmea, e para tratar a dor crÈnica em um paciente
BRPI0412924A (pt) tratamento pré-operatório de dor pós-operatória
MX2023003258A (es) Tratamiento de enfermedades mediadas por nf-kb.
BR0311180A (pt) Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos
DE69627298D1 (de) Verwendung von sklareolide für die behandlung von excessiven zellwachstumskrankheiten
JP3162929U (ja) 治療用指圧具
RU2300401C1 (ru) Способ реабилитации больных с переломами длинных костей
SU950354A1 (ru) Способ лечени синдрома зап стного канала
DE60024408D1 (de) Verwendung von trizyklischen antidepressiva zur behandlung von kopfschmerzen
DE60131100D1 (de) Verfahren zur behandlung bestimmter augenkrankheiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition